Literature DB >> 27208815

Identifying grey matter changes in schizotypy using partial least squares correlation.

Kristina Wiebels1, Karen E Waldie2, Reece P Roberts3, Haeme R P Park2.   

Abstract

Neuroimaging research into the brain structure of schizophrenia patients has shown consistent reductions in grey matter volume relative to healthy controls. Examining structural differences in individuals with high levels of schizotypy may help elucidate the course of disorder progression, and provide further support for the schizotypy-schizophrenia continuum. Thus far, the few studies investigating grey matter differences in schizotypy have produced inconsistent results. In the current study, we used a multivariate partial least squares (PLS) approach to clarify the relationship between psychometric schizotypy (measured by the Oxford-Liverpool Inventory of Feelings and Experiences) and grey matter volume in 49 healthy adults. We found a negative association between all schizotypy dimensions and grey matter volume in the frontal and temporal lobes, as well as the insula. We also found a positive association between all schizotypy dimensions and grey matter volume in the parietal and temporal lobes, and in subcortical regions. Further correlational analyses revealed that positive and disorganised schizotypy were strongly associated with key regions (left superior temporal gyrus and insula) most consistently reported to be affected in schizophrenia and schizotypy. We also compared PLS with the typically used General Linear Model (GLM) and demonstrate that PLS can be reliably used as an extension to voxel-based morphometry (VBM) data. This may be particularly valuable for schizotypy research due to PLS' ability to detect small, but reliable effects. Together, the findings indicate that healthy schizotypal individuals exhibit structural changes in regions associated with schizophrenia. This adds to the evidence of an overlap of phenotypic expression between schizotypy and schizophrenia, and may help establish biological endophenotypes for the disorder.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gray matter volume; Neuroanatomy; Schizophrenia; Schizotypy; Structural PLS

Mesh:

Year:  2016        PMID: 27208815     DOI: 10.1016/j.cortex.2016.04.011

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  9 in total

1.  Perspectives on Machine Learning for Classification of Schizotypy Using fMRI Data.

Authors:  Kristoffer H Madsen; Laerke G Krohne; Xin-Lu Cai; Yi Wang; Raymond C K Chan
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

2.  Developmental Trajectories of Cortical Thickness in Relation to Schizotypy During Adolescence.

Authors:  Mélodie Derome; Emiliana Tonini; Daniela Zöller; Marie Schaer; Stephan Eliez; Martin Debbané
Journal:  Schizophr Bull       Date:  2020-03-05       Impact factor: 9.306

3.  Association of schizotypy with striatocortical functional connectivity and its asymmetry in healthy adults.

Authors:  Yi Wang; Ulrich Ettinger; Thomas Meindl; Raymond C K Chan
Journal:  Hum Brain Mapp       Date:  2017-10-11       Impact factor: 5.038

4.  Increased resting perfusion of the hippocampus in high positive schizotypy: A pseudocontinuous arterial spin labeling study.

Authors:  Gemma Modinos; Alice Egerton; Katrina McMullen; Anna McLaughlin; Veena Kumari; Gareth J Barker; Steve C R Williams; Fernando Zelaya
Journal:  Hum Brain Mapp       Date:  2018-06-08       Impact factor: 5.038

5.  Cognitive Functioning and Schizotypy: A Four-Years Study.

Authors:  Penny Karamaouna; Chrysoula Zouraraki; Stella G Giakoumaki
Journal:  Front Psychiatry       Date:  2021-01-08       Impact factor: 4.157

6.  Association Between Trait Empathy and Resting Brain Activity in Women With Primary Dysmenorrhea During the Pain and Pain-Free Phases.

Authors:  Wanghuan Dun; Tongtong Fan; Qiming Wang; Ke Wang; Jing Yang; Hui Li; Jixin Liu; Hongjuan Liu
Journal:  Front Psychiatry       Date:  2020-11-26       Impact factor: 4.157

7.  Cortical and subcortical neuroanatomical signatures of schizotypy in 3004 individuals assessed in a worldwide ENIGMA study.

Authors:  Matthias Kirschner; Benazir Hodzic-Santor; Mathilde Antoniades; Igor Nenadic; Tilo Kircher; Axel Krug; Tina Meller; Dominik Grotegerd; Alex Fornito; Aurina Arnatkeviciute; Mark A Bellgrove; Jeggan Tiego; Udo Dannlowski; Katharina Koch; Carina Hülsmann; Harald Kugel; Verena Enneking; Melissa Klug; Elisabeth J Leehr; Joscha Böhnlein; Marius Gruber; David Mehler; Pamela DeRosse; Ashley Moyett; Bernhard T Baune; Melissa Green; Yann Quidé; Christos Pantelis; Raymond Chan; Yi Wang; Ulrich Ettinger; Martin Debbané; Melodie Derome; Christian Gaser; Bianca Besteher; Kelly Diederen; Tom J Spencer; Paul Fletcher; Wulf Rössler; Lukasz Smigielski; Veena Kumari; Preethi Premkumar; Haeme R P Park; Kristina Wiebels; Imke Lemmers-Jansen; James Gilleen; Paul Allen; Petya Kozhuharova; Jan-Bernard Marsman; Irina Lebedeva; Alexander Tomyshev; Anna Mukhorina; Stefan Kaiser; Anne-Kathrin Fett; Iris Sommer; Sanne Schuite-Koops; Casey Paquola; Sara Larivière; Boris Bernhardt; Alain Dagher; Phillip Grant; Theo G M van Erp; Jessica A Turner; Paul M Thompson; André Aleman; Gemma Modinos
Journal:  Mol Psychiatry       Date:  2021-10-27       Impact factor: 13.437

8.  Neuroanatomical changes in people with high schizotypy: relationship to glutamate levels.

Authors:  Gemma Modinos; Alice Egerton; Anna McLaughlin; Katrina McMullen; Veena Kumari; David J Lythgoe; Gareth J Barker; André Aleman; Steve C R Williams
Journal:  Psychol Med       Date:  2017-12-04       Impact factor: 7.723

9.  Brain structural correlates of schizotypal signs and subclinical schizophrenia nuclear symptoms in healthy individuals.

Authors:  Tina Meller; Simon Schmitt; Ulrich Ettinger; Phillip Grant; Frederike Stein; Katharina Brosch; Dominik Grotegerd; Katharina Dohm; Susanne Meinert; Katharina Förster; Tim Hahn; Andreas Jansen; Udo Dannlowski; Axel Krug; Tilo Kircher; Igor Nenadić
Journal:  Psychol Med       Date:  2020-06-24       Impact factor: 7.723

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.